8 February 2018 EMA/221190/2018 Human Medicines Evaluation Division

List of nationally authorised medicinal products Active substance(s): misoprostol (gastrointestinal indication)

Procedure No.: PSUSA/00010291/201706

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation

MRP/DCP Authorisation

National

MAH of product in the member

Member State

country)

number

Authorisation

state

where product is

Number Cytotec 200 microgram Tablets Cytotec 200 microgram tablets Cytotec 0,2 mg tabletter CYTOTEC 200 microgrammes, comprimé sécable CYTOTEC 200 microgram tabletten Cytotec 200 Mikrogramm Tabletten Misoprostol CYTOTEC 200 microgrammes, comprimés CYTOTEC 200 microgrammes, comprimés Cytotec 200 Mikrogramm Tabletten Cytotec 0,2 mg comprimidos Cytotec 0,2 mg tabletter Cytotec Cytotec 0,2 mg tabletti Cytotec, tabletter Cytotec, 200 μg, tabletki Cyprostol® - Tabletten

not not not not

Cytotec 0,2 mg comprimidos CYTOTEC 200 microgrammes, comprimé sécable CYTOTEC 200 mcg δισκία Cytotec®, tabletten 200 microgram Cytotec 200 microgramos comprimidos Cytotec 0,2 mg tabletter CYTOTEC 200 mcg compresse

not available not available

8628628 34009 328 785 8 1

not available not available not available not available not available

EMA/221190/2018

available available available available

not available not available

BE134093 2007079404

PFIZER HEALTHCARE IRELAND PFIZER LIMITED PFIZER OY PFIZER HOLDING FRANCE (S.C.A.) CONTINENTAL PHARMA, INC. CONTINENTAL PHARMA, INC.

not available

2007079404

CONTINENTAL PHARMA, INC.

LU

not available

BE134093

CONTINENTAL PHARMA, INC.

BE

not not not not not not not not

BE134093 8628636 00/8063 880109 10710 11978 R/2716 1-19557

BE PT NO IS FI DK PL AT

40410/07/19-5-2008 RVG 13724 58.403

CONTINENTAL PHARMA, INC. LABORATÓRIOS PFIZER, LDA. PFIZER AS PFIZER APS PFIZER OY PFIZER APS PFIZER EUROPE MA EEIG PFIZER CORPORATION AUSTRIA GESELLSCHAFT M.B.H. LABORATÓRIOS PFIZER, LDA. PFIZER HOLDING FRANCE (S.C.A.) PFIZER HELLAS, A.E. PFIZER B.V. PFIZER, S.L.

11033 026488015

PFIZER AB CONTINENTAL PHARMA, INC.

SE IT

available available available available available available available available

PA 822/118/1 PL 00057/0956 10710 34009 328 786 4 2

authorised IE UK FI FR BE LU

PT FR GR NL ES

Page 2/2

Misoprostol (gastrointestinal indication) - European Medicines Agency

Feb 8, 2018 - PFIZER HEALTHCARE IRELAND. IE. Cytotec 200 microgram tablets not available. PL 00057/0956. PFIZER LIMITED. UK. Cytotec 0,2 mg tabletter not available. 10710. PFIZER OY. FI. CYTOTEC 200 microgrammes, comprimé sécable not available. 34009 328 786 4 2. PFIZER HOLDING FRANCE. (S.C.A.).

89KB Sizes 6 Downloads 271 Views

Recommend Documents

misoprostol (gastrointestinal indication): CMDh scientific conclusions ...
Apr 7, 2018 - **Uterine rupture has been uncommonly reported after prostaglandin intake during the second or third trimester of pregnancy. Uterine ruptures occurred particularly in multiparous women or in women with a caesarean section scar. Package

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

misoprostol (gynaecological indication - termination of pregnancy ...
Mar 10, 2018 - Follow-up visits after medical termination of pregnancy with misoprostol are considered obligatory due to the risk of foetal malformations in case of method failure and ongoing pregnancy. It is important that both the summary of produc

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

misoprostol (gynaecological indication labour induction): List of ...
Page 1. Page 2. μικρογραμμάρια σύστημα για ενδοκολπική χορήγηση μικρογραμμάρια σύστημα για ενδοκολπική χορήγηση. Page 3. Misodel 200 mikrogramů.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

dexlansoprazole, lansoprazole - European Medicines Agency
European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. 13 September 2017. EMA/727763/2017. Human Medicines Evaluation Division. List of nationally authorised medicinal products. Active substance(s): dexlansop